Diagnostics Latest Reports

15 years+ Industry research experience. Only Company which focuses on small product segmentation reports.

According to this research report, the global allergy diagnostics market globally was USD 4,890.4 Million in 2022 expanding with a growth rate of 12.8% and is approximately projected for USD 9,050 Million by 2030.

The allergy diagnosis term refers to a significant initial step for effectual allergy treatment. This allergy diagnostic is the main step in treating patients that are suffering from allergic diseases. Some leading allergic diseases are rhinitis, asthma, angioedema, conjunctivitis, urticaria, and eczema, whereas conditions like drug, food, and insect allergies can affect large populations worldwide. The latest allergy test is convenient and precise compared to the before-taken tests. These allergy tests also recognize particular triggers for an individual’s allergic reactions with the help of thorough medical records. Also, this procedure is essential in drug development and the manufacturing process of allergy treatments.

Growth Factors

Through the high prevalence and increasing burden of allergic diseases, the latest allergy diagnostic market for the same is projected to grow up at a faster rate as the requirement for allergy diagnostics is mostly dominated by the rising innovative techniques in the commodity segment and in opposite end-use industries, the limited advantages of allergy diagnostics procedures, and the sterilization problem for packaged foods. Moreover, the latest diagnostic strategy for allergies and researches on advancements for treatment are likely to propel the growth of the allergy diagnostics market in the forthcoming years. In addition, allergy diagnostics is progressively more utilized for the expansion of self-purifying channels and the cleaning of numerous products, specifically meat and poultry bundling. This, in turn, is likely to have a positive influence on the market.

On the other hand, strict regulatory guidelines, and major financial investments are responsible for restraining the allergy diagnostics market growth sector. Also, cost expenditure and the lack of awareness towards allergic diseases are anticipated to slow down the market growth over the forecast period.

Regional Analysis

The geographical split of the allergy diagnostics market comprises North America, Europe, Asia-Pacific, and the Rest of the World. Geographically, the Asia-Pacific is expected to have the largest market share in the global allergy diagnostics market in the forthcoming years owing to the growing investments by governments to support research activities and the enhancement of life sciences research infrastructure in rising economies. Moreover, North America dominates the allergy diagnostics market due to the increasing awareness regarding the treatment process, and the growing scale of hospitals with well-developed laboratories. Also, the rise in population in rising countries like India and China is likely to fuel market growth in the future. Similarly, Europe and the Rest of the World are expected to drive the allergy diagnostics market in the coming years.

Report Attribute Details
The market size value in 2022 USD 4,890.4 million
The revenue forecast in 2030 USD 9,050 million
Growth Rate CAGR of 12.8% from 2022 to 2030
The base year for estimation 2021
Historical data 2018 – 2020
Forecast period 2022 – 2030
Top Manufacturers Thermo Fisher Scientific Inc., Siemens Healthineers, bioMérieux SA, Omega Diagnostics Group PLC, HYCOR Biomedical, R-Biopharm AG, Lincoln Diagnostics Inc., Stallergenes Greer, HOB Biotech Group Co, Hitachi Chemical Co Ltd, and Danaher Corporation
By Product Type Luminometers, Assay Kits, Immunoassay & ELISA Analyzers, Services
By Allergen Type Inhaled, Food, Others
By End-UserHospitals, Diagnostic Laboratories, Academic Research Institutes, Others
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Top Market Players

Major market players leading in the allergy diagnostics market are Thermo Fisher Scientific Inc., Siemens Healthineers, bioMérieux SA, Omega Diagnostics Group PLC, HYCOR Biomedical, R-Biopharm AG, Lincoln Diagnostics Inc., Stallergenes Greer, HOB Biotech Group Co, Hitachi Chemical Co Ltd, and Danaher Corporation.

This report segments the global allergy diagnostics market as follows:

Global Allergy Diagnostics Market: By Product Type

  • Luminometers
  • Assay Kits
  • Immunoassay & ELISA Analyzers
  • Services

Global Allergy Diagnostics Market: By Allergen Type

  • Inhaled
  • Food
  • Others


Global Allergy Diagnostics Market: By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Academic Research Institutes
  • Others

Global Allergy Diagnostics Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
Total Reports : 1
Up